https://kstockbriefing.com
![[Disclosure] PSK Holdings (031980) – Setting of Record Date or Closure Period of Shareholder Register / 2024-12-16](https://kstockbriefing.com/wp-content/uploads/2026/05/포맷변환피에스케이홀딩스.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary PSK Holdings set December 31, 2024, as the record date and established a shareholder register closure period from January 1 to January 15, 2025, to determine eligible shareholders for the 35th Annual General Meeting of Shareholders. 📊 [Key Disclosure Details & Major Figures Summary] 📝 Editor’s…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Ocean has set December 31, 2024, as the record date to determine shareholders eligible to exercise voting rights at the 25th Annual General Meeting of Shareholders. No separate period for closure of the shareholder register will be designated. 📊 [Key Disclosure Details & Financial Highlights]…
![[Disclosure] Hana Micron (067310) – Decision on Closure of Shareholders’ Register (Record Date) for Cash and In-Kind Dividend / 2024-12-16](https://kstockbriefing.com/wp-content/uploads/2026/06/포맷변환-하나마이크론.jpg)
Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hana Micron set December 31, 2024, as the record date to determine shareholders entitled to the 24th term dividend. 📊 Key Disclosure Content & Financial Figures Summary 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Dividend Record Date Filing and Future Dividend Disclosures This filing…
Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hana Micron set December 31, 2024, as the record date to determine shareholders entitled to exercise voting rights at the 24th Annual General Meeting of Shareholders, and corrected the board resolution date to December 16, 2024, due to a clerical error. 📊 Key Disclosure Content &…
Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hana Micron set December 31, 2024, as the record date to determine shareholders entitled to the 24th term dividend, and corrected the board resolution date to December 16, 2024, due to a clerical error. 📊 Key Disclosure Content & Financial Figures Summary 📝 Editor’s Comment (Key…
![[Disclosure] SK Hynix (000660 / SKHY) – Setting of Shareholder Register Closure Period or Record Date / 2024-12-16](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환SK하이닉스-3.jpg)
Fact Source: Financial Supervisory Service DARTMarket: KOSPI (000660) 💡 3-Second Summary SK Hynix has set December 31, 2024, as the record date to determine eligible voting shareholders for its 77th Annual General Meeting of Shareholders. 📊 Key Disclosure Contents & Financial Figures 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of AGM Record Date and…
Fact Source: Financial Supervisory Service DARTMarket: KOSPI (000660) 💡 3-Second Summary Pursuant to an amendment to its Articles of Incorporation, SK Hynix will set and disclose its FY2024 year-end dividend record date via a future board resolution in 2025, rather than using the traditional calendar year-end date. 📊 Key Disclosure Contents & Financial Figures 📝…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has disclosed the setting of December 31, 2024, as the record date and the closure of its shareholder register (suspension of entry of alteration in the register) from January 1, 2025, to January 31, 2025, to determine entitled shareholders for its 14th Annual General…
![[Disclosure] Hanwha Aerospace (012450) – Setting of Record Date or Closure of Register of Shareholders / 2024-12-16](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환-한화에어로스페이스.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Shareholders holding Hanwha Aerospace shares as of December 31, 2024, will be granted voting rights for the upcoming 48th Annual General Meeting of Shareholders. 📊 [Key Disclosure Details & Summary of Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Confirmation of Agendas via Convocation Notice of…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion received a recommendation for marketing authorization from the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) for CT-P41, a biosimilar referencing Prolia and Xgeva, across 30 European countries for all target indications including osteoporosis and prevention of skeletal-related events….